Interaction of hIAPP with Model Raft Membranes and Pancreatic β‐Cells: Cytotoxicity of hIAPP Oligomers
暂无分享,去创建一个
Norbert Opitz | Roland Winter | Katrin Weise | N. Opitz | R. Winter | A. Gohlke | Andrea Gohlke | Katrin Weise | Diana Radovan | Diana Radovan
[1] R. Kayed,et al. Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases* , 2004, Journal of Biological Chemistry.
[2] D. Dickson,et al. Dimeric Amyloid β Protein Rapidly Accumulates in Lipid Rafts followed by Apolipoprotein E and Phosphorylated Tau Accumulation in the Tg2576 Mouse Model of Alzheimer's Disease , 2004, The Journal of Neuroscience.
[3] C. Czeslik,et al. Interaction of IAPP and insulin with model interfaces studied using neutron reflectometry. , 2009, Biophysical journal.
[4] C. Haass,et al. Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts , 2003, The Journal of cell biology.
[5] E. Gratton,et al. Partitioning of dual-lipidated peptides into membrane microdomains: lipid sorting vs peptide aggregation. , 2004, Journal of the American Chemical Society.
[6] R. Raffai,et al. Cholesterol Published, JLR Papers in Press, January 23, 2003. DOI 10.1194/jlr.R300007-JLR200 , 2003, Journal of Lipid Research.
[7] S. Ji,et al. Cholesterol Is an Important Factor Affecting the Membrane Insertion of β-Amyloid Peptide (Aβ1–40), Which May Potentially Inhibit the Fibril Formation* , 2002, The Journal of Biological Chemistry.
[8] P. Lansbury,et al. Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. , 2002, Biochemistry.
[9] R. Seidel,et al. Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes. , 2009, Journal of molecular biology.
[10] J. Brender,et al. Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy. , 2009, Journal of the American Chemical Society.
[11] J. McLaurin,et al. Cholesterol, a Modulator of Membrane-associated Aβ-fibrillogenesis , 2003, Annals of the New York Academy of Sciences.
[12] U Aebi,et al. Amyloid fibril formation from full-length and fragments of amylin. , 2000, Journal of structural biology.
[13] Ralf Langen,et al. Identifying Structural Features of Fibrillar Islet Amyloid Polypeptide Using Site-directed Spin Labeling* , 2004, Journal of Biological Chemistry.
[14] R. Winter,et al. Effect of pressure on islet amyloid polypeptide aggregation: revealing the polymorphic nature of the fibrillation process. , 2008, Biochemistry.
[15] Christian Leisner,et al. Raft lipids as common components of human extracellular amyloid fibrils. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] S. Kahn,et al. Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. , 1999, Diabetes.
[17] Z. Salamon,et al. Effects of sphingomyelin, cholesterol and zinc ions on the binding, insertion and aggregation of the amyloid Aβ1−40 peptide in solid‐supported lipid bilayers , 2006, The FEBS journal.
[18] Roland Winter,et al. Inhibiting Islet Amyloid Polypeptide Fibril Formation by the Red Wine Compound Resveratrol , 2009, Chembiochem : a European journal of chemical biology.
[19] C. Verchere,et al. Islet amyloid polypeptide and type 2 diabetes , 2003, Experimental Gerontology.
[20] E. Gazit,et al. The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. , 2003, Biochemistry.
[21] E. Gratton,et al. Visualizing association of N-ras in lipid microdomains: influence of domain structure and interfacial adsorption. , 2006, Journal of the American Chemical Society.
[22] B. Kurganov,et al. Aggregation of liposomes induced by the toxic peptides Alzheimer’s Aβs, human amylin and prion (106–126): facilitation by membrane-bound GM1 ganglioside , 2004, Peptides.
[23] L. Serpell,et al. Structural characterisation of islet amyloid polypeptide fibrils. , 2004, Journal of molecular biology.
[24] A. Meister,et al. Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy. , 2007, Biophysical journal.
[25] B. Wolozin. A fluid connection: Cholesterol and Aβ , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. Kahn,et al. The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes , 2001 .
[27] V. Höllt. The mu opioid receptor: Molecular and functional aspects , 2004 .
[28] Roland Winter,et al. Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study. , 2009, Journal of the American Chemical Society.
[29] H. Makino,et al. Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. , 1989, Biochemical and biophysical research communications.
[30] U. Aebi,et al. Watching amyloid fibrils grow by time-lapse atomic force microscopy. , 1999, Journal of molecular biology.
[31] S. Jayasinghe,et al. Structure of α-Helical Membrane-bound Human Islet Amyloid Polypeptide and Its Implications for Membrane-mediated Misfolding* , 2008, Journal of Biological Chemistry.
[32] H. Reber,et al. Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. , 2010, The American journal of pathology.
[33] J. Brender,et al. Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide. , 2008, Journal of the American Chemical Society.
[34] J. McLaurin,et al. Cholesterol, a Modulator of Membrane‐Associated Aβ‐Fibrillogenesis , 2002, Pharmacopsychiatry.
[35] N. Opitz,et al. Fluorescence microscopy studies on islet amyloid polypeptide fibrillation at heterogeneous and cellular membrane interfaces and its inhibition by resveratrol , 2009, FEBS letters.
[36] Maarten F. M. Engel,et al. Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane , 2008, Proceedings of the National Academy of Sciences.
[37] M. Angelova,et al. Lipid swelling and liposome formation mediated by electric fields , 1988 .
[38] A. Miranker,et al. Phospholipid catalysis of diabetic amyloid assembly. , 2004, Journal of molecular biology.
[39] S. Jayasinghe,et al. Lipid membranes modulate the structure of islet amyloid polypeptide. , 2005, Biochemistry.
[40] A. Fink,et al. Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins. , 2007, Biochimica et biophysica acta.
[41] B. de Kruijff,et al. Visualizing detergent resistant domains in model membranes with atomic force microscopy , 2001, FEBS letters.
[42] A. Miranker,et al. Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide. , 2006, Biochemistry.
[43] L. Johnston,et al. Preferential accumulation of Abeta(1-42) on gel phase domains of lipid bilayers: an AFM and fluorescence study. , 2007, Biochimica et biophysica acta.
[44] C. Betsholtz,et al. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[45] R. Turner,et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[46] H. Waldmann,et al. The lipid modifications of Ras that sense membrane environments and induce local enrichment. , 2009, Angewandte Chemie.
[47] B. Jena,et al. Nano-scale imaging and dynamics of amylin-membrane interactions and its implication in type II diabetes mellitus. , 2008, Methods in cell biology.
[48] D. Milardi,et al. Calcium-activated membrane interaction of the islet amyloid polypeptide: implications in the pathogenesis of type II diabetes mellitus. , 2008, Archives of biochemistry and biophysics.
[49] Maarten F. M. Engel. Membrane permeabilization by Islet Amyloid Polypeptide. , 2009, Chemistry and physics of lipids.
[50] B. Göke,et al. Islet amyloid polypeptide (IAPP;amylin) influences the endocrine but not the exocrine rat pancreas. , 1990, Biochemical and biophysical research communications.
[51] S. Theander,et al. Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. , 2004, Endocrinology.
[52] H. Waldmann,et al. Influence of the lipidation motif on the partitioning and association of N-Ras in model membrane subdomains. , 2009, Journal of the American Chemical Society.
[53] U. Aebi,et al. Human Amylin Oligomer Growth and Fibril Elongation Define Two Distinct Phases in Amyloid Formation* , 2004, Journal of Biological Chemistry.
[54] D. W. Hayden,et al. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[55] Hai Lin,et al. Amyloid ion channels: a common structural link for protein-misfolding disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[56] B. Kagan,et al. Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (*) , 1996, The Journal of Biological Chemistry.
[57] Maarten F. M. Engel,et al. Islet amyloid polypeptide inserts into phospholipid monolayers as monomer. , 2006, Journal of molecular biology.
[58] A. Herrmann,et al. Die Lipidmodifikationen von Ras passen sich an die Membranumgebung an und beeinflussen die lokale Konzentration , 2009 .
[59] U. Aebi,et al. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. , 2004, Journal of molecular biology.
[60] J. Bernhagen,et al. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. , 1999, Journal of molecular biology.
[61] O. Petersen,et al. Calcium oscillations [12] , 1989 .
[62] D. Harrison,et al. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. , 1999, Diabetes.